Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00839098 · ClinicalTrials.gov registry record · NA
Powered Seating Function Usage Among Veterans - Compliance and Coaching
A NA study of Use of Power Wheelchairs and Power Seat Functions, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT00839098: Completed NA study of Use of Power Wheelchairs and Power Seat Functions, sponsored by VA Office of Research and Development.
NCT00839098 is a NA study of Use of Power Wheelchairs and Power Seat Functions that has completed, run by VA Office of Research and Development. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00839098, a NA study of Use of Power Wheelchairs and Power Seat Functions, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this randomized control study is to evaluate the use of electric powered wheelchairs and powered seating function patterns of Veterans to determine how usage patterns relate to activity, participation, and seating discomfort. In addition, it will be determined if a training program or a training program with a virtual coach will improve compliance of clinical practice guidelines for pressure relief, upper limb preservation, and discomfort management. The virtual coach is a portable, programmable intelligent reminder designed to enhance a person's use of their power wheelchair and power seat functions.
Primary Outcome
Compliance rate is a measure of compliance with the recommendation of using powered seating functions (moderate or maximum range of tilt, at least once every hour, for 2 minutes). The participant had to follow the recommended position, duration, and frequency to be considered as compliant and performed successful repositioning exercise. The compliance rate of a participant was the number of successful repositioning exercise divided by the sum of the number of successful repositioning exercise an
Conditions Studied
Interventions
- OTHER Instruction Group: Power seat function usage instruction- verbal and written instruction
- OTHER Instruction and Virtual Coach Group: Power seat function usage instruction- verbal, written, and virtual coach
Study Locations (1)
Pennsylvania
- VA Pittsburgh Health Care System - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-11 |
| Phase | NA |
What the finished NCT00839098 record still lists
NCT00839098 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Use of Power Wheelchairs and Power Seat Functions appearing as the primary indexed condition, and to 2 interventions - of which Instruction Group: Power seat function usage instruction- verbal and written instruction is the first listed.
NCT00839098 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00839098 about?
NCT00839098 is a clinical study titled "Powered Seating Function Usage Among Veterans - Compliance and Coaching". The purpose of this randomized control study is to evaluate the use of electric powered wheelchairs and powered seating function patterns of Veterans to determine how usage patterns relate to activity, participation, and seating discomfort. In addition, it will be determined if a training program or...
What is the current status of trial NCT00839098?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2011-11. Estimated completion is 2014-11.
What conditions does trial NCT00839098 study?
This clinical trial studies the following conditions: Use of Power Wheelchairs and Power Seat Functions.
What interventions are being tested in trial NCT00839098?
The interventions under investigation include: Instruction Group: Power seat function usage instruction- verbal and written instruction (OTHER), Instruction and Virtual Coach Group: Power seat function usage instruction- verbal, written, and virtual coach (OTHER).
Who is sponsoring clinical trial NCT00839098?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00839098 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00839098's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia